Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.
Publication
, Journal Article
Burns, TM; Sanders, DB; Kaminski, HJ; Wolfe, GI; Narayanaswami, P; Venitz, J
Published in: Muscle Nerve
May 2015
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Muscle Nerve
DOI
EISSN
1097-4598
Publication Date
May 2015
Volume
51
Issue
5
Start / End Page
635 / 637
Location
United States
Related Subject Headings
- United States
- Treatment Outcome
- Off-Label Use
- Neurology & Neurosurgery
- Mycophenolic Acid
- Myasthenia Gravis
- Insurance Coverage
- Immunosuppressive Agents
- Humans
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Burns, T. M., Sanders, D. B., Kaminski, H. J., Wolfe, G. I., Narayanaswami, P., & Venitz, J. (2015). Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States. Muscle Nerve, 51(5), 635–637. https://doi.org/10.1002/mus.24608
Burns, Ted M., Donald B. Sanders, Henry J. Kaminski, Gil I. Wolfe, Pushpa Narayanaswami, and Jurgen Venitz. “Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.” Muscle Nerve 51, no. 5 (May 2015): 635–37. https://doi.org/10.1002/mus.24608.
Burns TM, Sanders DB, Kaminski HJ, Wolfe GI, Narayanaswami P, Venitz J. Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States. Muscle Nerve. 2015 May;51(5):635–7.
Burns, Ted M., et al. “Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.” Muscle Nerve, vol. 51, no. 5, May 2015, pp. 635–37. Pubmed, doi:10.1002/mus.24608.
Burns TM, Sanders DB, Kaminski HJ, Wolfe GI, Narayanaswami P, Venitz J. Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States. Muscle Nerve. 2015 May;51(5):635–637.
Published In
Muscle Nerve
DOI
EISSN
1097-4598
Publication Date
May 2015
Volume
51
Issue
5
Start / End Page
635 / 637
Location
United States
Related Subject Headings
- United States
- Treatment Outcome
- Off-Label Use
- Neurology & Neurosurgery
- Mycophenolic Acid
- Myasthenia Gravis
- Insurance Coverage
- Immunosuppressive Agents
- Humans
- 11 Medical and Health Sciences